(Q82230939)
Statements
Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid (English)
J Mellergård
M Edström
M Vrethem
J Ernerudh
scientific article published on 09 December 2009
No description defined